Deficiency of Arg1 in brain myeloid cells preferentially promotes a transcriptomic signature that is more homeostatic and less phagocytic, possibly inhibiting their crucial transition from a homeostatic to a disease-associated state during amyloidosis, leading to more Aβ deposition. Here, ARG1 is linked to amyloidosis.